Cullinan Associates’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $603K | Hold |
|
|||||
|
2025
Q2 | $569K | Hold |
|
|||||
|
2025
Q1 | $524K | Hold |
|
|||||
|
2024
Q4 | $457K | Hold |
|
|||||
|
2024
Q3 | $544K | Hold |
|
|||||
|
2024
Q2 | $500K | Hold |
|
|||||
|
2024
Q1 | $455K | Buy |
|
|||||
|
2023
Q4 | $464K | Sell |
|
|||||
|
2023
Q3 | $489K | Hold |
|
|||||
|
2023
Q2 | $484K | Buy |
|
|||||
|
2023
Q1 | $423K | Sell |
|
|||||
|
2022
Q4 | $535K | Buy |
|
|||||
|
2022
Q3 | $357K | Buy |
|
|||||
|
2022
Q2 | $380K | Hold |
|
|||||
|
2022
Q1 | $395K | Sell |
|
|||||
|
2021
Q4 | $408K | Sell |
|
|||||
|
2021
Q3 | $488K | Buy |
|
|||||
|
2021
Q2 | $529K | Sell |
|
|||||
|
2021
Q1 | $505K | Hold |
|
|||||
|
2020
Q4 | $558K | Hold |
|
|||||
|
2020
Q3 | $514K | Hold |
|
|||||
|
2020
Q2 | $516K | Buy |
|
|||||
|
2020
Q1 | $456K | Sell |
|
|||||
|
2019
Q4 | $575K | Buy |
|
|||||
|
2019
Q3 | $401K | Hold |
|
|||||
|
2019
Q2 | $421K | Sell |
|
|||||
|
2019
Q1 | $443K | Hold |
|
|||||
|
2018
Q4 | $396K | Buy |
|
|||||
|
2018
Q3 | $310K | Hold |
|
|||||
|
2018
Q2 | $272K | Hold |
|
|||||
|
2018
Q1 | $291K | Hold |
|
|||||
|
2017
Q4 | $302K | Hold |
|
|||||
|
2017
Q3 | $309K | Hold |
|
|||||
|
2017
Q2 | $300K | Hold |
|
|||||
|
2017
Q1 | $267K | Sell |
|
|||||
|
2016
Q4 | $265K | Buy |
|
|||||
|
2016
Q3 | $284K | Hold |
|
|||||
|
2016
Q2 | $297K | Hold |
|
|||||
|
2016
Q1 | $261K | Buy |
|
|||||
|
2015
Q4 | $215K | Hold |
|
|||||
|
2015
Q3 | $230K | Hold |
|
|||||
|
2015
Q2 | $246K | Hold |
|
|||||
|
2015
Q1 | $247K | Buy |
|